Evidence map›Paper›PMID 42846757›Full record

ArticleFrontiers in oncology2026

Localization-guided segmentation of Gliomas via 3D ReFusionNet.

Ling Chen, Jinzhu Chang, Qi Zhang, Fang Ren, Jianjun Song, Jianzhou Yang, Xiangyu Guo

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ling Chen *Department of Radiology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Jinzhu Chang *Department of Anesthesiology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Qi ZhangDepartment of Radiology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Fang RenDepartment of Radiology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Jianjun SongDepartment of Radiology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Jianzhou YangDepartment of Public Health and Preventive Medicine, Changzhi Medical College, Changzhi, China.
Xiangyu GuoDepartment of Public Health and Preventive Medicine, Changzhi Medical College, Changzhi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study presents a localization-guided two-stage 3D framework for the automated segmentation of brain tumors. Methods: ReFusionNet first estimates a single region of interest containing the tumor-bearing region and then segments the whole tumor, tumor core, and enhancing tumor within the localized volume. The framework was evaluated on the UPENN-GBM and BraTS 2021 datasets using recall, precision, Dice score, and the 95th-percentile Hausdorff distance (HD95). Results: On the UPENN-GBM test set, ReFusionNet-A achieved Dice scores of 0.90, 0.81, and 0.77 for the whole tumor, tumor core, and enhancing tumor, respectively. Its corresponding HD95 values were 11.68, 21.53, and 10.49. The localization-guided models generally showed higher precision and lower HD95 values for selected regions, but lower recall and Dice scores occurred in some tumor-core and enhancing-tumor comparisons. On BraTS 2021, ReFusionNet-C achieved competitive Dice scores, although its HD95 values were not the lowest among the models compared. Conclusion: ReFusionNet achieved competitive segmentation performance on the evaluated public datasets. Its principal observed advantages were higher precision and lower HD95 values in selected tumor regions, while performance gains were not uniform across all metrics.

Indexed as

brain tumor segmentationlocalization-guided segmentationlocalization modulemask moduleMRI

Identifiers

PMID42846757
PMCPMC13643124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.